SEC Form 10-Q filed by Tilray Brands Inc.
$TLRY
Medicinal Chemicals and Botanical Products
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/5/2024 | $2.25 → $2.75 | Neutral | Alliance Global Partners |
| 11/2/2022 | $3.90 | Mkt Perform | Bernstein |
| 7/29/2022 | $3.00 | Hold → Sell | The Benchmark Company |
| 3/4/2022 | $9.00 | Hold → Buy | Canaccord Genuity |
| 1/11/2022 | $7.40 → $6.90 | Neutral | Cantor Fitzgerald |
| 1/7/2022 | $11.80 → $7.40 | Neutral | Cantor Fitzgerald |
| 11/18/2021 | $10.00 | Underweight | Barclays |
| 11/1/2021 | $18.00 → $11.80 | Overweight → Neutral | Cantor Fitzgerald |
8-K - Tilray Brands, Inc. (0001731348) (Filer)
8-K - Tilray Brands, Inc. (0001731348) (Filer)
DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously
Bernstein initiated coverage of Tilray with a rating of Mkt Perform and set a new price target of $3.90
The Benchmark Company downgraded Tilray from Hold to Sell and set a new price target of $3.00
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
4 - Tilray Brands, Inc. (0001731348) (Issuer)
MONTAUK, N.Y., June 26, 2025 (GLOBE NEWSWIRE) -- Montauk Brewing Co., the brewery known for capturing the essence of coastal living and a craft beer brand by Tilray Brands, Inc. company (NASDAQ:TLRY, TSX:TLRY), is partnering with premium lifestyle brand Faherty to craft a limited-edition beer and beachside inspired apparel collection that embodies the carefree spirit of Montauk and effortless style. The collaboration brings together Montauk's passion for quality brewing with Faherty's commitment to modern, heritage-inspired apparel. To celebrate the 13th anniversary of Montauk Brewing, the two brands collaborated on The Après Surf Beer, a tropical edition of The Surf Beer Golden Ale from
NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced the publication of a scientific study. This new research focuses on comparing the bioavailability of different cannabinoid formulations, taking a step forward in our understanding of medical cannabis. The study aimed to assess the pharmacokinetic parameters and relative bioavailability of two D9-tetrahydrocannabinol: cannabidiol (THC:CBD) formulations. (A) A
SAVONA, Italy, June 24, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, today announced a significant milestone in its European expansion with the introduction of three new medical cannabis flower varieties in Italy. Through its wholly-owned subsidiary, FL Group, Tilray has become the first company in Italy to receive official authorization from the Ministero della Salute (Italian Ministry of Health) to import and distribute proprietary Tilray Medical-brand